[beta2-Sympathomimetics: dangers in asthma therapy? Lessons from the SMART1 Study].
Riedl-Seifert
R
R
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D013566:Sympathomimetics / Q000009:adverse effects* / Q000145:classification / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D013566:Sympathomimetics